-
UK gene therapy hub network awarded £18m in funding
pharmatimes
March 18, 2021
Medical research charity LifeArc and the Medical Research Council (MRC) have announced three investments totalling £18m for the creation of a UK network of gene therapy hubs.
-
Mogrify Enters Research Collaboration with MRC LMB
contractpharma
January 12, 2021
Research project aims to develop novel protein expression systems via cell reprogramming.
-
International consortium creates ‘open platform’ for COVID-19 drug discovery
pharmatimes
December 18, 2020
An international consortium, led by Cambridge Medical Research Council (MRC) researchers, has developed an ‘open platform’ to advance and prioritise drug discovery and repurposing efforts for COVID-19.
-
Drawbridge Health partners with University of Cambridge Researchers for use of OneDraw™ Blood Collection Device in COVID-19 and Other Clinical Studies
prnasia
December 04, 2020
Drawbridge Health and the Medical Research Council (MRC) Epidemiology Unit, University of Cambridge (UK) today announced the use of the OneDraw™ Blood Collection Device1 for remote blood sample collection in a large-scale surveillance study currently ...
-
MRC and LifeArc announce grants for Gene Therapy Innovation Hubs in UK
europeanpharmaceuticalreview
May 08, 2020
The UK MRC and LifeArc are making £16 million available as grants to fund the establishment of Gene Therapy Innovation Hubs to improve resources for researchers and manufacturers.
-
LifeArc, MRC create £16m fund to set up gene therapy hubs
pharmatimes
May 06, 2020
The Medical Research Council (MRC) and independent medical research charity LifeArc are streaming £16 million into establishing a network of gene therapy innovation hubs.
-
Genetic studies: a powerful tool for testing combination therapies
pharmaceutical
November 19, 2018
A genetic study by MRC has suggested that combining lipoprotein lipase (LPL) enhancers with cholesterol lowering agents further reduces the risk of heart attacks than cholesterol lowering agents alone.
-
New alliance strives to advance human-based drug evaluation
pharmatimes
November 09, 2018
Medicines Discovery Catapult and the Medical Research Council (MRC) Centre for Drug Safety Science (CDSS) at the University of Liverpool have announced plans...
-
Research backs halving chemo after bowel cancer surgery
pharmatimes
July 19, 2018
Some patients receiving chemotherapy after surgery for bowel cancer might only need three months of treatment rather than the six months currently given, according to new research published in the Lancet Oncology.
-
MRC awards Bristol researcher £1.2M to investigate immune defence against microbes
pharmatimes
May 02, 2018
University of Bristol researcher Dr Borko Amulic has been awarded a prestigious Career Development Award worth £1.2 million by the Medical Research Council (MRC) to lead research into ...